Publications
- Sustainability of biologic treatment in paediatric patients with Crohn's disease: population-based registry analysis2024 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Medicine in Pilsen
- Serum and Mucosal CD30 in Pediatric Inflammatory Bowel Diseases: Useful Biomarker for Diagnosis and Disease Activity Monitoring?2023 | Second Faculty of Medicine, Third Faculty of Medicine
- Postvaccination Immunogenicity of BNT162b2 SARS-CoV-2 Vaccine and Its Predictors in Pediatric Inflammatory Bowel Disease2023 | Second Faculty of Medicine
- Predictive value of tissue calprotectin for disease recurrence after ileocecal resection in pediatric Crohn's disease2022 | Second Faculty of Medicine, Third Faculty of Medicine
- Adalimumab versus infliximab in pediatric patients with Crohn's disease: A propensity-score analysis and predictors of treatment escalation2022 | Second Faculty of Medicine
- Is It Useful to Monitor Thiopurine Metabolites in Pediatric Patients with Crohn's Disease on Combination Therapy? A Multicenter Prospective Observational Study2021 | Second Faculty of Medicine, First Faculty of Medicine
- Risk factors for dermatological complications of anti-TNF therapy in a cohort of children with Crohn's disease2021 | Second Faculty of Medicine
- Limited clinical significance of tissue calprotectin levels in bowel mucosa for the prediction of complicated course of the disease in children with ulcerative colitis2019 | Second Faculty of Medicine
- Prediction of Thiopurine Metabolite Levels Based on Haematological and Biochemical Parameters2019 | Second Faculty of Medicine
- Fecal calprotectin is not a clinically useful marker for the prediction of the early nonresponse to exclusive enteral nutrition in pediatric patients with Crohn disease2018 | Second Faculty of Medicine
Loading network view...